Abbott India Limited | ABBOTINDIA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
6,989
8,027
9,260
10,797
12,738
Cash flow Operating Act...
Cash flow Operating Activities
4,9916,2617,2679,4778,934
Investments in PPE
Investments in PPE
-123-157-233-441-341
Cash flow Investing Act...
Net cash used for Investment Activities
-2,570-4,012-718-3,958-1,477
Dividend Paid
Dividend Paid
1,4091,6655,3125,8445,844
Cash flow Financing Act...
Net cash provided by Financing Activities
-1,428-2,168-5,818-6,374-6,387
Cash at beginning of period
Cash at beginning of period
3771,3701,4512,1831,327
Cash at end of period
Cash at end of period
1,3701,4512,1831,3272,397
Free Cash Flow
Free Cash Flow
4,868
6,104
7,034
9,036
8,593